RECOMMENDATION:
Take one capsule/tablet daily
BENEFICIAL EFFECTS:
Florical is indicated for otosclerosis. The idea of using
Florical is not unlike that of using fluoride for the teeth- it speeds
up hardening of bone.
EACH CAPSULE CONTAINS:
Fluoride: 3.75 mg Calcium :145 mg (oyster shell).
LEGAL STATUS:
Dietary supplement in accordance with the Dietary Supplement
Health and Education Act (1994)
USAGE:
Florical can be used three times a day for otosclerosis. After two
years, the dose may be reduced to one capsule per day. Once the
otospongiosis phase of otosclerosis is over and there is otosclerosis
documented by conductive hearing loss, Florical may be stopped.
ADVERSE REACTION:
Lower extremity pain has been reported (ankle pain) and can be resolved
by stopping Florical for 30 days; the pain resolves in a few weeks, then
the patient restarts the Florical at a lower dosage, pacing themselves
and taking as much Florical as can be tolerated.
Epigastric symptoms occur approximately 9% of the time, diarrhea and dry
skin have occurred occasionally.
NOTE:
Please consult your doctor before taking this or any
medication.
CAUTION:
This Product should not be used by children under 12 years of age
SHELF LIFE:
5 Years from date of manufacture
- The only medical treatment for otosclerosis
- Dietary supplement, not a drug
- Three capsules a day
- Safe and effective
- 100 capsules of Fluoride and Calcium
Computerized Data from
Cause Clinic
on NaF Therapy for Cochlear Otospongiosis |
Daily Dose,
Naf/mg |
Duration
of Rx/ yr |
Total Cases |
Hearing improved
% (10db or more) |
Hearing
Stabilized
% |
Hearing Worse,
% (10db or more) |
| Stapedial Fixation With Sensorineural
Progression |
| 1,5 |
1-4 |
212 |
1.06 |
86.79 |
11.79 |
| 45 |
1 |
59 |
5.08 |
88.13 |
6.77 |
| Pure Cochlear Otospongiosis |
| 1,5 |
1-4 |
325 |
8.61 |
82.46 |
8.92 |
| 45 |
1 |
34 |
8.82 |
85.29 |
5.88 |
Note:
Since 25% of otospongiosis with sensorineural loss stabilizes
spontaneously, the percentage due to NaF therapy should be reduced by
25%.
HELLENIC DRUG ORGANIZATION LICENSE
(P.O.BOX 370), Corinth, 20100, Greece
Tel.: +30 27410 26631 • Fax: +30 27410 85030
Mob.: 6944 280764
pharmagel.gr
e-mail:
pharmage@otenet.gr
© Pharmagel Co.